- AngioDynamics (NASDAQ:ANGO) Q4 results: Revenues: $86.9M (-7.0%); Operating Loss: ($9.3M); Net Loss: ($10.9M) (+74.7%); Loss Per Share: ($0.30) (+74.8%); Non-GAAP EPS: $0.19 (-5.0%); Quick Assets: $48.8M (+43.5%); CF Ops: $19M (+2.7%).
- FY2018 Guidance: Revenue: $352M - 359M; Non-GAAP EPS: $0.64 - 0.68; FCF: >$35M.
AngioDynamics Q4 revenues down 7%; updates FY18 guidance
Recommended For You
More Trending News
About ANGO Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ANGO | - | - |
AngioDynamics, Inc. |